Search Orphan Drug Designations and Approvals
-
Generic Name: | Temoporfin |
---|---|
Date Designated: | 10/28/1999 |
Orphan Designation: | Palliative treatment of recurrent, refractory or second primary squamous cell carcinomas of the head and neck in patients considered to be incurable with surgery or radiotherapy. |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Biolitec Pharma Ireland Ltd. United Drug House Dublin Ireland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-